Roche's Avastin fails key colon cancer trial
Shares of Roche Holdings open 11% lower on Wednesday after the company says the key drug Avastin doesn’t reduce the risk of colon cancer returning any more than just using chemotherapy.
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here